SE8008339L - 24,24-difluoro-1alfa,25-dihydroxikolekalciferol - Google Patents

24,24-difluoro-1alfa,25-dihydroxikolekalciferol

Info

Publication number
SE8008339L
SE8008339L SE8008339A SE8008339A SE8008339L SE 8008339 L SE8008339 L SE 8008339L SE 8008339 A SE8008339 A SE 8008339A SE 8008339 A SE8008339 A SE 8008339A SE 8008339 L SE8008339 L SE 8008339L
Authority
SE
Sweden
Prior art keywords
dihydroxikolekalciferol
1alfa
difluoro
Prior art date
Application number
SE8008339A
Other languages
English (en)
Swedish (sv)
Inventor
Luca H F De
H K Schnoes
N Ikekawa
Y Tanaka
Y Kobayashi
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of SE8008339L publication Critical patent/SE8008339L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48Halogenated derivatives
    • C07C35/52Alcohols with a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Character Discrimination (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
SE8008339A 1979-03-28 1980-11-27 24,24-difluoro-1alfa,25-dihydroxikolekalciferol SE8008339L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/024,848 US4201881A (en) 1979-03-28 1979-03-28 24,24-Difluoro-1α,25-dihydroxycholecalciferol

Publications (1)

Publication Number Publication Date
SE8008339L true SE8008339L (sv) 1980-11-27

Family

ID=21822707

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8008339A SE8008339L (sv) 1979-03-28 1980-11-27 24,24-difluoro-1alfa,25-dihydroxikolekalciferol

Country Status (15)

Country Link
US (1) US4201881A (enExample)
JP (2) JPS6342618B2 (enExample)
AU (1) AU530015B2 (enExample)
BE (1) BE882143A (enExample)
CH (1) CH650240A5 (enExample)
DK (1) DK147300C (enExample)
FR (1) FR2452481A1 (enExample)
GB (2) GB2045765B (enExample)
IE (1) IE49753B1 (enExample)
IL (1) IL58526A (enExample)
IT (1) IT1140776B (enExample)
NL (1) NL7920190A (enExample)
NZ (1) NZ191900A (enExample)
SE (1) SE8008339L (enExample)
WO (1) WO1980002028A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
EP0073465B1 (de) * 1981-08-28 1986-02-05 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cholecalciferolderivate
CA1221031A (en) * 1982-05-17 1987-04-28 Alfred Boris Use of a cholecalciferol derivative
US4456689A (en) * 1982-05-17 1984-06-26 Becton Dickinson And Company Competitive protein binding assay using an organosilane-silica gel separation medium
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
EP0205285B1 (en) * 1985-05-30 1989-08-09 Taisho Pharmaceutical Co. Ltd Vitamin d3 derivatives
WO1987003282A1 (fr) * 1985-11-21 1987-06-04 Taisho Pharmaceutical Co., Ltd. Derive de la vitamine d3
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
US7718637B2 (en) * 2007-12-28 2010-05-18 Wisconsin Alumni Research Foundation (20S)-23,23-difluoro-methylene-19-nor-bishomopregnacalciferol-vitamin D analogs
JP5504898B2 (ja) 2010-01-08 2014-05-28 セントラル硝子株式会社 ジフルオロシクロプロパン化合物の製造方法
GB202016614D0 (en) 2020-10-20 2020-12-02 King S College London Compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741996A (en) * 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3969700A (en) * 1974-04-10 1976-07-13 International Business Machines Corporation Regional context maximum likelihood error correction for OCR, keyboard, and the like
FR2267590B1 (enExample) * 1974-04-10 1977-05-20 Ibm
JPS5729745B2 (enExample) * 1974-09-25 1982-06-24
US3993675A (en) * 1975-02-24 1976-11-23 Hoffmann-La Roche Inc. Process for the preparation of 1α,25-dihydroxycholecalciferol
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same

Also Published As

Publication number Publication date
GB2045765A (en) 1980-11-05
CH650240A5 (de) 1985-07-15
AU530015B2 (en) 1983-06-30
GB2045765B (en) 1983-06-15
IE49753B1 (en) 1985-12-11
FR2452481B1 (enExample) 1984-10-19
BE882143A (fr) 1980-07-01
GB2067567A (en) 1981-07-30
IL58526A (en) 1983-05-15
NL7920190A (nl) 1981-01-30
IE800619L (en) 1980-09-28
FR2452481A1 (fr) 1980-10-24
WO1980002028A1 (en) 1980-10-02
JPS6342618B2 (enExample) 1988-08-24
IT8020508A0 (it) 1980-03-11
JPS63179855A (ja) 1988-07-23
IT1140776B (it) 1986-10-10
AU5581080A (en) 1980-10-02
DK147300C (da) 1984-12-24
IL58526A0 (en) 1980-01-31
DK505080A (da) 1980-11-27
US4201881A (en) 1980-05-06
JPS56500296A (enExample) 1981-03-12
GB2067567B (en) 1983-03-02
NZ191900A (en) 1984-11-09
DK147300B (da) 1984-06-12
JPH0146504B2 (enExample) 1989-10-09

Similar Documents

Publication Publication Date Title
DK537780A (da) 1,8-naphthyridin-derivater
FI792046A7 (fi) Oktahydropyrazolo/3,4-g/kinoliner
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
DK3881A (da) Substituerede 9,10-anthracen-bishydrazoner
FI793663A7 (fi) 1,2,4,5-tetra-alkyl-4-arylpiperidiner
SE8008339L (sv) 24,24-difluoro-1alfa,25-dihydroxikolekalciferol
SE7803411L (sv) 2,6-dialkoxibensamider
IT1151077B (it) 24,24-difluoro-25-idrossicolecalciferolo
FI803403A7 (fi) Uusia pyridotienotriatsideja.
FI803727L (fi) 2,3-indolidionderivat
NO802888L (no) 2-klor-4,5-disubstituerte-thiazoler
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
NO793494L (no) Sylinderlaas i.
FI792047A7 (fi) Oktahydro-2h-pyrrolo/3,4-g/kinoliner
FI801473A7 (fi) Framstaellningsfoerfarande foer 5-merkapto-1,2,3-triazoler
BE883295A (fr) 6,7-secoergolines
BE875273A (fr) 0-carbamoyloximes de 2,3-dihydro-4h-1-benzo-pyranne-4-ones
BE881358A (fr) 25-hydroxycholecalciferol-26,23-lactone
FI803041A7 (fi) Framstaellning av 2-oxo-dihydrobenso/d/1,3/oxaziner
DK136379A (da) 4,6-dihalogensteroider
NO802405L (no) 2-sulfinyl-5-sulfonyl-1,3,4-thiadiazolderivater
DE2953592A1 (de) 24,24-difluoro-25-hydroxycholecalciferol
DK446582A (da) 24,24-difluor-1alfa,15-dihydro-5,6-transcholecalciferol
DK430479A (da) 2,6-dihalogenbensylestere
NO812109L (no) Z-profilfoeringsinnretning.